A study of 2.4 million cancer cases shows that men are more often diagnosed at advanced stages than women. Experts suggest this gap may relate to healthcare engagement.

Preclinical research indicates that nitrosylcobalamin can cross the blood-brain barrier and accumulate in glioblastoma tissue. The compound shows synergistic potential with existing therapies by potentially overcoming tumor resistance mechanisms.